The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
350 jobs Number of planned job creations
Announcement Date
18 June 2008
Employment effect (start)
1 January 2009
Foreseen end date
31 December 2011
Description
Russian Institute Europharm Company will expand its business to Slovakia. The pharmaceutical company started the building of its subsidiary in industrial zone Kežmarok-Pradiareň. This greenfield investment will amount to SKK 1 billion. In total 350 new jobs will be created there by the end of 2011. According to Mayor of Kežmarok, Igor Šajtlava, the first stage of the investment will be completed by the end of 2008. About 80 new jobs will be created there in production of substances based on fish eggs from 2009.
Eurofound (2008), Institute Europharm, Business expansion in Slovakia, factsheet number 66760, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/66760.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
